Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Phathom Pharmaceuticals, Inc. (PHAT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 57,250,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal diseases. Co.'s primary product candidate, vonoprazan, is an oral small molecule potassium-competitive acid blocker (P-CAB). P-CABs are a class of medicines that block acid secretion in the stomach. Vonoprazan has shown effects and has demonstrated clinical results as an agent in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of H. pylori infection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 7,500 61,419
Total Buy Value $0 $0 $58,580 $486,703
Total People Bought 0 0 1 3
Total Buy Transactions 0 0 3 9
Total Shares Sold 20,286 3,732,423 3,736,493 3,752,906
Total Sell Value $191,642 $30,255,939 $30,305,472 $30,443,179
Total People Sold 2 3 3 3
Total Sell Transactions 2 5 7 13
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 144
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-06-07 4 AS $35.05 $79,353 D/D (2,264) 942,105     -
   Guzzo Anthony J. VP, Chief Accounting OfficerOf   •       –      –    2021-06-04 3 IO $0.00 $0 D/D 0 804     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-06-02 4 AS $35.18 $151,274 D/D (4,300) 944,369     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-06-01 4 AS $35.55 $401,130 D/D (11,211) 948,669     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-28 4 AS $35.37 $322,305 D/D (8,905) 959,880     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-27 4 AS $36.99 $313,953 D/D (8,453) 968,785     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-26 4 AS $36.45 $452,747 D/D (12,358) 977,238     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-25 4 AS $36.16 $396,079 D/D (10,947) 989,596     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-24 4 AS $35.58 $377,810 D/D (10,594) 1,000,543     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-21 4 AS $35.74 $416,300 D/D (11,648) 1,011,137     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-20 4 AS $35.10 $249,140 D/D (7,098) 1,022,785     -
   Socks David A Director   –       •      –    2021-05-20 4 AS $33.76 $120,687 I/I (3,482) 1,300,945     -
   Socks David A Director   –       •      –    2021-05-19 4 AS $31.96 $1,184,819 I/I (36,518) 1,304,427     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-14 4 AS $35.00 $3,500 D/D (100) 1,029,883     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-13 4 AS $35.33 $3,533 D/D (100) 1,029,983     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-12 4 AS $35.39 $417,359 D/D (11,776) 1,030,083     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-07 4 AS $35.03 $35,415 D/D (1,011) 1,041,859     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-06 4 AS $35.01 $7,072 D/D (202) 1,042,870     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-05 4 AS $35.14 $243,731 D/D (6,936) 1,043,072     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-04 4 AS $35.50 $697,808 D/D (19,360) 1,050,008     -
   Nabulsi Azmi Chief Operating Officer   •       –      –    2021-05-04 4 AS $36.15 $164,302 I/I (4,457) 765,700     -
   Takeda Pharmaceutical Co Ltd 10% Owner   –       –       •   2021-05-03 4 AS $37.60 $560,041 D/D (14,632) 1,069,368     -
   Nabulsi Azmi Chief Operating Officer   •       –      –    2021-05-03 4 AS $37.85 $384,354 I/I (10,043) 770,157     -
   Socks David A Director   –       •      –    2021-04-06 4 AS $34.96 $664,684 I/I (17,882) 1,340,945     -
   Socks David A Director   –       •      –    2021-04-05 4 AS $35.69 $797,405 I/I (22,118) 1,358,827     -
  144 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us